Nora Therapeutics, Inc. — Form D
Nora Therapeutics, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-04-13. The offering totals $24.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-04-13
- Form: D
- Accession: 0001461695-09-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $24.0M
- Amount sold: $1.0M
- Remaining: $23.0M
- Minimum investment: $16K
- Investors: 4
- Date of first sale: 2009-03-31
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-130159
Issuer
- Name: Nora Therapeutics, Inc.
- CIK: 0001461695
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 530 LYTTON AVENUE, 2ND FLOOR, PALO ALTO, CA, 94301
- Phone: 1-650-479-5331
Officers, directors & promoters (24)
| Name | Role | Location |
|---|
| Julie McHugh | Director | Owing Mills, MD |
| David Schnell | Director | New York, NY |
| CHEN YU | Director | PALO ALTO, CA |
| Julie McHugh | Executive Officer | Owing Mills, MD |
| Donald J Hayden, Jr. | Director | Philadelphia, PA |
| Joseph L Turner, Jr. | Director | Palo Alto, CA |
| Chen K Yu | Director | Palo Alto, CA |
| David K Schnell | Director | Palo Alto, CA |
| Dennis K Fenton | Director | Palo Alto, CA |
| Donald K Hayden, Jr. | Director | Palo Alto, CA |
| Anupam K Dalal | Director | Palo Alto, CA |
| Anupam J Dalal | Director | Palo Alto, CA |
| Martin J Vogelbaum | Director | Palo Alto, CA |
| Chen E Yu | Director | Palo Alto, CA |
| Dennis J Fenton | Director | Palo Alto, CA |
| David E Schnell | Director | Palo Alto, CA |
| Bryant E Fong | Director | SAN FRANCISCO, CA |
| Christopher B McClain | Executive Officer | Owing Mills, MD |
| Martin K Vogelbaum | Director | New York, NY |
| Jeffrey K Tong | Director | Palo Alto, CA |
| Jeffrey K Tong | Executive Officer | Palo Alto, CA |
| Darryl L Carter | Executive Officer | Owing Mills, MD |
| Alan K Colowick | Director | Palo Alto, CA |
| Alan K Colowick | Executive Officer | Palo Alto, CA |
Other filings by this issuer (5)
More